…
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; and ancillary services, such as multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Income before tax | 147.10M | 135.00M | 110.30M | 81.20M | -18.80M |
| Minority interest | -180.60M | -146.20M | 141.60M | -141.60M | 117.40M |
| Net income | -168.10M | -11.90M | 87.00M | 70.70M | 1.30M |
| Selling general administrative | 138.70M | 120.90M | 102.20M | 104.00M | 97.10M |
| Gross profit | 745.60M | 647.50M | 574.90M | 491.40M | 379.80M |
| Reconciled depreciation | 152.60M | 116.60M | 114.80M | 98.80M | 94.80M |
| Ebit | 348.80M | 328.00M | 310.40M | 263.10M | 143.60M |
| Ebitda | 501.40M | 446.10M | 460.00M | 401.00M | 277.80M |
| Depreciation and amortization | 152.60M | 118.10M | 149.60M | 137.90M | 134.20M |
| Operating income | 348.80M | 328.00M | 345.20M | 302.20M | 246.60M |
| Other operating expenses | 2864.50M | 2415.30M | 2179.00M | 1898.60M | 1626.00M |
| Interest expense | 201.70M | 193.00M | 234.90M | 221.00M | 201.80M |
| Tax provision | 134.60M | 3.60M | 23.30M | 10.50M | -20.10M |
| Net interest income | -201.70M | -205.30M | -234.90M | -221.00M | -201.80M |
| Non recurring | - | - | 1.60M | 24.30M | 56.20M |
| Income tax expense | 134.60M | 0.30M | 23.30M | 10.50M | -20.10M |
| Total revenue | 3114.30M | 2743.30M | 2539.30M | 2225.10M | 1860.10M |
| Total operating expenses | 495.80M | 319.50M | 214.60M | 164.90M | 145.70M |
| Cost of revenue | 2368.70M | 2095.80M | 1964.40M | 1733.70M | 1480.30M |
| Total other income expense net | -201.70M | -193.00M | -234.90M | -221.00M | -201.80M |
| Net income from continuing ops | 12.50M | 111.90M | 87.00M | 70.70M | 1.30M |
| Net income applicable to common shares | - | - | -54.60M | -81.20M | -155.60M |
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Total assets | 7890.00M | 7019.10M | 6682.10M | 6117.60M | 5413.20M |
| Intangible assets | 45.70M | 54.80M | 42.30M | 43.70M | 46.90M |
| Other current assets | 182.40M | 110.30M | 79.00M | 39.30M | 27.40M |
| Total liab | 4254.80M | 3657.20M | 6682.10M | 6117.60M | 5413.20M |
| Total stockholder equity | 1789.70M | 1987.20M | 1998.20M | 1089.00M | 115.60M |
| Other current liab | 314.30M | 235.10M | 239.30M | 247.00M | 243.20M |
| Common stock | 1.30M | 1.30M | 1.30M | 0.90M | 0.50M |
| Capital stock | 1.30M | 1.30M | 1.30M | 0.90M | 435.00M |
| Retained earnings | -737.30M | -569.20M | -557.30M | -502.70M | -431.80M |
| Other liab | - | - | 35.00M | 402.60M | 440.60M |
| Good will | 5068.00M | 4326.00M | 4137.10M | 3911.80M | 3468.00M |
| Other assets | - | - | 122.30M | 5171.50M | 554.00M |
| Cash | 269.50M | 195.90M | 282.90M | 389.90M | 317.90M |
| Total current liabilities | 624.40M | 523.00M | 493.40M | 536.80M | 556.80M |
| Current deferred revenue | - | - | 3.20M | 64.40M | 109.80M |
| Net debt | 3433.90M | 2865.70M | 2646.80M | 2904.60M | 2879.00M |
| Short term debt | 142.40M | 110.90M | 99.30M | 100.50M | 103.60M |
| Short long term debt | 101.40M | 73.30M | 62.80M | 60.40M | 64.40M |
| Short long term debt total | 3703.40M | 3061.60M | 2929.70M | 3294.50M | 3196.90M |
| Other stockholder equity | 2520.90M | 2497.60M | 2478.00M | 1622.30M | 173.40M |
| Property plant equipment | - | - | 1155.70M | 953.80M | 854.70M |
| Total current assets | 1119.40M | 895.00M | 921.00M | 946.10M | 801.50M |
| Long term investments | 215.40M | 184.10M | 190.30M | 88.70M | 90.30M |
| Net tangible assets | - | - | -1567.80M | 1089.00M | -2357.10M |
| Short term investments | - | - | - | - | 90.00M |
| Net receivables | 579.10M | 513.60M | 456.30M | 430.20M | 382.20M |
| Long term debt | 3268.90M | 2701.80M | 2559.00M | 2878.40M | 2792.40M |
| Inventory | 88.40M | 75.20M | 71.40M | 61.10M | 56.40M |
| Accounts payable | 208.70M | 177.00M | 151.60M | 124.90M | 100.20M |
| Noncontrolling interest in consolidated entity | - | - | 942.70M | 880.60M | 766.50M |
| Accumulated other comprehensive income | 4.80M | 57.50M | 76.20M | -31.50M | -61.00M |
| Common stock total equity | - | - | 1.30M | 0.90M | 435.00M |
| Retained earnings total equity | - | - | -557.30M | -502.70M | -431.80M |
| Non currrent assets other | 57.50M | 28.70M | 144.20M | 59.10M | 27.00M |
| Non current assets total | 6770.60M | 6124.10M | 5761.10M | 5171.50M | 4611.70M |
| Capital lease obligations | 333.10M | 286.50M | 307.90M | 355.70M | 340.10M |
| Long term debt total | - | - | 2559.00M | 2878.40M | 2792.40M |
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Investments | -488.50M | -239.70M | -82.30M | -331.70M | -88.40M |
| Change to liabilities | - | - | 0.00M | 0.00M | 0.00M |
| Total cashflows from investing activities | - | - | -307.90M | -331.70M | -88.40M |
| Net borrowings | - | - | -644.20M | -55.50M | 204.60M |
| Total cash from financing activities | 262.00M | -155.20M | 42.10M | 316.30M | 66.70M |
| Change to operating activities | - | - | -125.40M | -149.20M | 122.50M |
| Net income | 12.50M | -11.90M | 87.00M | 70.70M | 1.30M |
| Change in cash | 73.60M | -87.00M | -107.00M | 71.70M | 225.20M |
| Begin period cash flow | 195.90M | 282.90M | 389.90M | 318.20M | 93.00M |
| End period cash flow | 269.50M | 195.90M | 282.90M | 389.90M | 318.20M |
| Total cash from operating activities | 300.10M | 293.80M | 158.80M | 87.10M | 246.90M |
| Issuance of capital stock | 0.00M | 0.00M | 882.90M | 581.80M | 0.00M |
| Depreciation | 152.60M | 118.10M | 114.80M | 98.80M | 94.80M |
| Other cashflows from investing activities | -22.20M | -6.50M | 83.70M | -274.10M | 59.10M |
| Dividends paid | - | 0.00M | 146.80M | 5.10M | 109.60M |
| Change to account receivables | -72.10M | -47.20M | -35.30M | -32.10M | -46.60M |
| Sale purchase of stock | - | - | 854.30M | -233.50M | -27.40M |
| Other cashflows from financing activities | -173.50M | -174.70M | -196.60M | 316.30M | -146.40M |
| Change to netincome | - | - | 45.90M | 35.60M | 25.30M |
| Capital expenditures | 90.40M | 88.80M | 80.60M | 57.60M | 42.90M |
| Change receivables | - | - | -35.30M | -32.10M | -46.60M |
| Cash flows other operating | - | - | -53.60M | -85.90M | 172.10M |
| Cash and cash equivalents changes | - | - | -107.00M | 71.70M | 225.20M |
| Change in working capital | -118.90M | -63.50M | -160.70M | -149.10M | 75.90M |
| Stock based compensation | 33.30M | 17.70M | 18.40M | 17.40M | 13.20M |
| Other non cash items | 89.10M | 235.10M | 77.40M | 40.40M | 83.60M |
| Free cash flow | 209.70M | 205.00M | 78.20M | 29.50M | 204.00M |
Sector: Healthcare Industry: Medical Care Facilities
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| SGRY Surgery Partners Inc |
0.03 0.13% |
23.20 | - | 31.15 | 0.97 | 1.76 | 2.11 | 13.68 |
| HCA HCA Healthcare, Inc. |
-12.49 2.46% |
494.99 | 14.27 | 13.46 | 1.21 | 291.34 | 1.83 | 8.99 |
| THC Tenet Healthcare Corporation |
-3.13 1.09% |
283.33 | 10.08 | 12.66 | 0.96 | 4.57 | 1.43 | 5.80 |
| FSNUY Fresenius SE & Co KGaA ADR |
0.06 0.42% |
14.62 | 16.87 | 9.44 | 0.42 | 0.78 | 0.79 | 5.37 |
| JDHIY JD Health International Inc |
- -% |
5.28 | 62.50 | 35.97 | 0.30 | 2.32 | 0.16 | 3.90 |
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; and ancillary services, such as multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
340 Seven Springs Way, Brentwood, TN, United States, 37027
615 234 5900
15000
| Name | Title | Year Born |
|---|---|---|
| Mr. Wayne Scott DeVeydt | Exec. Chairman | 1970 |
| Mr. J. Eric Evans | CEO & Director | 1977 |
| Ms. Jennifer B. Baldock | Exec. VP and Chief Admin. & Devel. Officer | 1971 |
| Mr. Anthony W. Taparo | Chief Growth Officer | 1966 |
| Mr. Bradley R. Owens | Pres of National Group | 1970 |
| Mr. David T. Doherty | Exec. VP & CFO | 1972 |
| Mr. Varun Gadhok | Sr. VP & Chief Information Officer | NA |
| Ms. Roxanne Womack | Sr. VP & Chief Compliance Officer | NA |
| Ms. Marissa A. Brittenham | Exec. VP & Chief Strategy Officer | 1985 |
| Mr. Harrison Bane | Group Pres of American | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.